Segment Information (Tables)

9 Months Ended

Sep. 30, 2020

Segment Reporting [Abstract]

Summary of Net sales and Operating Profit by Segment

Net sales and operating profit by segment are as follows (in millions):

	Net Sales				Operating (Loss) Profit
	Three Months Ended				Three Months Ended
	September 30,				September 30,
	2020		2019		2020			2019
Americas and Global Businesses	$	1,253.5	$	1,212.3	$	413.9		$	394.3
EMEA		339.7		351.8		84.6			93.7
Asia Pacific		336.1		328.3		113.4			109.6
Corporate Functions		-		-		(103.8	)		(96.6	)
Total	$	1,929.3	$	1,892.4
Inventory and manufacturing-related charges						(2.3	)		(11.6	)
Intangible asset amortization						(149.7	)		(146.6	)
Restructuring and other cost reduction initiatives						(16.2	)		(5.4	)
Quality remediation						(10.0	)		(21.5	)
Acquisition, integration and related						(9.1	)		2.6
Litigation						(19.3	)		(42.8	)
European Union Medical Device Regulation						(2.0	)		(11.4	)
Other charges						(0.3	)		(18.5	)
Operating profit					$	299.2		$	245.8

	Net Sales				Operating (Loss) Profit
	Nine Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020			2019
Americas and Global Businesses	$	3,147.6	$	3,703.0	$	865.7		$	1,211.5
EMEA		915.1		1,186.5		213.4			350.4
Asia Pacific		876.5		967.0		284.4			341.1
Corporate Functions		-		-		(319.4	)		(331.8	)
Total	$	4,939.2	$	5,856.5
Inventory and manufacturing-related charges						(4.3	)		(47.7	)
Intangible asset amortization						(445.0	)		(436.9	)
Goodwill and intangible asset impairment						(645.0	)		(70.1	)
Restructuring and other cost reduction initiatives						(89.2	)		(17.0	)
Quality remediation						(35.8	)		(64.6	)
Acquisition, integration and related						(15.7	)		(8.5	)
Litigation						(100.4	)		(48.0	)
Litigation settlement gain						-			23.5
European Union Medical Device Regulation						(19.1	)		(18.1	)
Other charges						(18.1	)		(83.1	)
Operating (loss) profit					$	(328.5	)	$	800.7